ArticleScientific reports2025
Integrated transcriptomics and proteomics reveal ferroptosis induced by B[a]P and BPDE in mouse hippocampal neurons.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The environmental pollutant Benzo[a]pyrene (B[a]P) and its ultimate metabolite B[a]P-7,8-diol-9,10-epoxide (BPDE) exhibit neurotoxic effects, yet the underlying molecular mechanisms remain enigmatic. Recently, ferroptosis has emerged as a potential player in B[a]P/BPDE-induced cellular damage. However, whether ferroptosis contributes to B[a]P/BPDE-induced neuron injury remains uncertain. We established a mouse model of learning and memory dysfunction through sub-chronic intragastric administration of B[a]P, with confirmation provided by behavioral alterations and pathological changes in the hippocampus. Furthermore, ferroptosis hallmarks, such as mitochondrial shrinkage, iron and glutamate metabolism disorders, and increased MDA level, were evident. Meanwhile, treatment with 1 mg/kg Ferrostatin-1 (Fer-1), a ferroptosis inhibitor, could effectively reduce hippocampal neuronal ferroptosis and improve learning and memory ability. HT22 cells were treated with 0, 0.5, and 0.75 µM BPDE, and ferroptosis was observed. Subsequent proteomic and transcriptomic analyses elucidated the underlying mechanisms of ferroptosis. Using integrated bi-omics and machine-learning algorithms, we delineated a network involving autophagy, ATP concentration, and molecule transport. Mechanistically, BPDE inhibited the transport of iron, amino acids and carbohydrates, decreased ATP content, increased ROS levels, and promoted autophagy, potentially leading to metabolic disorders and imbalance of oxidation and antioxidant systems, culminating in ferroptosis. These findings expand our understanding of B[a]P/BPDE neurotoxicity and pave the way for future investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.